Use of interleukin-11 as therapeutic agent for heart disease
US8361966B2 · kind B2 · utility
18Cited by
9References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2007 |
| Grant date | Jan 29, 2013 |
| Priority date | — |
| Expiry date | May 6, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention demonstrates the myocardial protective effects of interleukin 11 in vivo, and provides preventive, therapeutic, or other types of drugs for heart disease using interleukin 11 as the active ingredient. The present invention, by utilizing the myocardial protective effects of interleukin 11, can suppress the progress of myocardial injury, prevent the onset of heart failure, or suppress the progress of heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.